Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

24.32
Delayed Data
As of Jul 20
 -0.43 / -1.74%
Today’s Change
15.15
Today|||52-Week Range
32.54
+45.89%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Henderson John Tannahill
Director
Sale9/09/201627,993$20.51$574.1K+19.80%
Henderson John Tannahill
Director
Buy9/09/201627,993$10.60$296.7K+19.80%
Capone Mark C
President & Chief Executive Officer
Buy8/19/201610,000$21.24$212.4K+14.34%
Capone Mark C
President & Chief Executive Officer
Sale9/30/20169,238$20.58$190.1K+18.17%
Capone Mark C
President & Chief Executive Officer
Sale9/17/20168,042$20.92$168.2K+16.53%
Riggsbee R Bryan
Chief Financial Officer
Sale9/30/20165,599$20.58$115.2K+18.17%
Lanchbury Jerry S
Chief Scientific Officer
Sale9/30/20165,459$20.58$112.3K+18.17%
Lanchbury Jerry S
Chief Scientific Officer
Sale9/17/20164,752$20.92$99.4K+16.53%
Marsh Richard M
Executive Vice President & General Counsel
Sale9/17/20164,606$20.92$96.4K+16.53%
Tobin Bernard
Sale9/30/20164,661$20.58$95.9K+18.17%
Page of 5